Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MS 10 - Evidence Based Care: Interpreting the Research and Enhancing Practice
- 15:45 - 17:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Symposium
- Track: Nursing/Palliative Care/Ethics
- Moderators:Caitlin Broderick, Pippa Labuc
-
+
MS 10.01 - Radiotherapy Management
15:45 - 16:05 | Presenter: Mary Duffy
- Abstract
No abstract available for this presentation
-
+
MS 10.02 - Interpreting Published Research
16:05 - 16:25 | Presenter: Angela Mary Tod
- Abstract
Loading... -
+
MS 10.03 - Community Outreach - Engaging in Primary Care
16:25 - 16:45 | Presenter: Lavinia Dobrea
- Abstract
Loading... -
+
MS 10.04 - Pre-Operative Support
16:45 - 17:05 | Presenter: Melissa Culligan
- Abstract
No abstract available for this presentation
-
+
MS 10.05 - Immunotherapy: The Latest
17:05 - 17:25 | Presenter: Beth Eaby-Sandy
- Abstract
Loading... -
+
MS 10.06 - Q&A
17:25 - 17:30
- Abstract
No abstract available for this presentation
-
+
OA 04 - Surgery from Minimal to Radical
- 15:45 - 17:30
- 10/16/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Surgery
-
+
OA 04.01 - Randomised Trial of Systematic Lymph Node Dissection versus Bilateral Mediastinal Lymphadenectomy in Patients with Non-Small Cell Carcinoma
15:45 - 15:55 | Presenter: Jaroslaw Kuzdzal | Author(s): Ł. Hauer, J. Hauer, J. Warmus, P. Kocon, Ł. Trybalski, Z. Grochowski, J. Włodarczyk, Tomasz Gil, T. Smęder
- Abstract
Loading... -
+
OA 04.02 - Feasibility of Pulmonary Resection Following Definitive Chemoradiotherapy for Primary Lung Carcinoma
15:55 - 16:05 | Presenter: Yasuhiro Hida | Author(s): K. Kaga, Tatsuya Kato, M. Aragaki, R. Nakada-Kubota, Y. Yagi, R. Chiba, Y. Matsui
- Abstract
Loading... -
+
- Abstract
Loading... -
+
OA 04.04 - Discussant - OA 04.01, OA 04.02, OA 04.03
16:15 - 16:30 | Presenter: Hiroyasu Yokomise
- Abstract
No abstract available for this presentation
-
+
OA 04.05 - Intermediate Results of ICG Anatomical Segmentectomy Based on the Virtual Segmentectomy Simulation
16:30 - 16:40 | Presenter: Yasuo Sekine | Author(s): D. Kaiho, T. Yun, E. Koh, T. Kamata, F. Ishibashi, T. Toyoda
- Abstract
Loading... -
+
OA 04.06 - Surgeon Practices for Post Resection Lung Cancer Surveillance: Comparisons of STS and ESTS Members
16:40 - 16:50 | Presenter: Leah Backhus | Author(s): P. Bhandari, Cecilia Pompili, A. Brunelli, N. Novoa, K. Naunheim, M. Edwards
- Abstract
Loading... -
+
OA 04.07 - Initial Results of Tubeless Single-Port Thoracoscopic Surgery for Pulmonary Tumor
16:50 - 17:00 | Presenter: Chao-Yu Liu | Author(s): P. Hsu, H. Chien, C. Hsieh
- Abstract
Loading... -
+
OA 04.08 - Is Lobe-Specific Lymph Node Dissection in Clinical N0-1 Non-Small Cell Lung Cancer Adequate for Pathological Nodal Staging
17:00 - 17:10 | Presenter: Apichat Tantraworasin | Author(s): S. Siwachat, N. Lertprasertsuke, S. Kongkarnka, J. Euathrongchit, Y. Wannasopha, N. Tanatip, E. Taioli, S. Saeteng
- Abstract
Loading... -
+
OA 04.09 - Discussant - OA 04.05, OA 04.06, OA 04.07, OA 04.08
17:10 - 17:25 | Presenter: Anthony Kim
- Abstract
No abstract available for this presentation
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.01 - First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups
15:45 - 15:55 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, X. Zhou, K.H. Lee, Kazuhiko Nakagawa, Seiji Niho, F. Tsuji, Rafael Rosell, J. Corral, M.R. Migliorino, A. Pluzanski, R. Linke, E.I. Sbar, T. Wang, H. Zhang, Tony SK Mok
- Abstract
Loading... -
+
OA 05.02 - Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis
15:55 - 16:05 | Presenter: Jhanelle Elaine Gray | Author(s): Isamu Okamoto, V. Sriuranpong, Johan F. Vansteenkiste, F. Imamura, J.S. Lee, Y. Pang, M. Cobo, K. Kasahara, R. Hodge, Brian B Lentrichia, S. Dearden, Suresh S Ramalingam
- Abstract
Loading... -
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading... -
+
OA 05.04 - Discussant - OA 05.01, OA 05.02, OA 05.03
16:15 - 16:30 | Presenter: Mark G Kris
- Abstract
No abstract available for this presentation
-
+
OA 05.05 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial
16:30 - 16:40 | Presenter: Myung-Ju Ahn | Author(s): D. Ross Camidge, M. Tiseo, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
OA 05.06 - Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer
16:40 - 16:50 | Presenter: Ben J Solomon | Author(s): Alice Shaw, Sai-Hong Ignatius Ou, Benjamin Besse, Enriqueta Felip, T.M. Bauer, R.A. Soo, A. Bearz, Chia-Chi Lin, J.S. Clancy, A. Abbattista, H. Thurm, G. Peltz, E.T. Masters, J. Martini, L.P. James, Takashi Seto
- Abstract
Loading... -
+
OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
16:50 - 17:00 | Presenter: Byoung Chul Cho | Author(s): R. Obermannová, A. Bearz, D. Kim, S. Orlov, G. Borra, Sang-We Kim, Pieter E. Postmus, S.A. Laurie, Keunchil Park, S.L. Geater, A.C. Bettini, K. Osborne, V.Q. Passos, Z. Chen, Rafal Dziadziuszko
- Abstract
Loading... -
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio | Author(s): K. Kiura, Takashi Seto, Kazuhiko Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Yuichiro Ohe, N. Nogami, H. Murakami, K. Takeuchi, S. Inamura, H. Kuriki, T. Shimada, T. Tamura
- Abstract
Loading... -
+
OA 05.09 - Discussant- OA 05.05, OA 05.06, OA 05.07, OA 05.08
17:10 - 17:25 | Presenter: Kentaro Tanaka
- Abstract
No abstract available for this presentation
-
+
OA 06 - Global Tobacco Control and Epidemiology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 511 + 512
- Type: Oral
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
-
+
OA 06.01 - Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening Program
15:45 - 15:55 | Presenter: William Kenneth Evans | Author(s): C. Gauvreau, W. Flanagan, S. Memon, N. Fitzgerald, John R Goffin, A. Miller
- Abstract
Loading... -
+
OA 06.02 - Final Report of the INHERIT EGFR Study - 33 Unrelated Kindreds Carrying Germline EGFR Mutations
15:55 - 16:05 | Presenter: Geoffrey R. Oxnard | Author(s): J.C. Heng, R. Chen, D.R. Koeller, K. Shane-Carson, R.H. Morgan, G.L. Wiesner, J.E. Garber
- Abstract
Loading... -
+
OA 06.03 - Comorbidity and Competing Causes of Death attenuate outcomes in the NLST.
16:05 - 16:15 | Presenter: Robert P Young | Author(s): Raewyn J Hopkins, G.D. Gamble
- Abstract
Loading... -
+
OA 06.04 - Discussant - OA 06.01, OA 06.02, OA 06.03
16:15 - 16:30 | Presenter: Anthonie Van Der Wekken
- Abstract
No abstract available for this presentation
-
+
OA 06.05 - Socioeconomic Factors Affecting Outcomes in Non-Small Cell Lung Cancer (NSCLC): A Large Population-Based Analysis
16:30 - 16:40 | Presenter: Yanyan Lou | Author(s): Bhagirathbhai Dholaria, A.E. Soyano, D. Hodge, S. Ailawadhi
- Abstract
Loading... -
+
OA 06.06 - Chr15q25 Locus Confers Risk of Lung Cancer, COPD and Smoking: Triple Whammy Effect in the ACRIN NLST Sub-Study (N=9,270)
16:40 - 16:50 | Presenter: Raewyn J Hopkins | Author(s): F. Duan, E. Greco, C. Chiles, G.D. Gamble, D.R. Aberle, Robert P Young
- Abstract
Loading... -
+
OA 06.07 - Survival Trends Among Non-Small Cell Lung Cancer (NSCLC) Patients Over A Decade: Impact of Initial Therapy at Academic Centers
16:50 - 17:00 | Presenter: Yanyan Lou | Author(s): Bhagirathbhai Dholaria, S. Ailawadhi, A.E. Soyano, D. Hodge, R. Manochakian, M.E. Menefee, E. Johnson, M. Thomas, S. Ko, R.C. Miller, M. Johnson, N. Patel, K. Mody, R. Joseph
- Abstract
Loading... -
+
OA 06.08 - Is Lung Cancer Screening Associated with a Negative Psychological Impact?
17:00 - 17:10 | Presenter: Ben Young | Author(s): M. Clark, L. Bedford, R. Das Nair, J. Robertson, K. Vedhara, D. Kendrick
- Abstract
Loading... -
+
OA 06.09 - Discussant - OA 06.05, OA 06.06, OA 06.07, OA 06.08
17:10 - 17:25 | Presenter: Norihiko Ikeda
- Abstract
No abstract available for this presentation
-
+
OA 07 - Biomarker for Lung Cancer
- 15:45 - 17:30
- 10/16/2017
- Location: Room 503
- Type: Oral
- Track: Biology/Pathology
- Moderators:Philip Christopher Mack, Shinichi Toyooka
-
+
- Abstract
Loading... -
+
OA 07.02 - Characteristics of Lung Cancer Cell-Free Tumor DNA (CfDNA) Shedding and Correlation with Tumor Burden as Measured by RECIST
15:55 - 16:05 | Presenter: Vincent K Lam | Author(s): L. Li, J. Wang, H.T. Tran, W. Rinsurongkawong, R.B. Lanman, J. Lewis, J. Roth, Stephen Swisher, Vassiliki A Papadimitrakopoulou, Jack Lee, Jianjun Zhang, John V Heymach
- Abstract
Loading... -
+
OA 07.03 - Circulating Tumor DNA Mutant Allele Frequency and Tumor Burden as Biomarkers for Response to Immune Checkpoint Blockade
16:05 - 16:15 | Presenter: Young Kwang Chae | Author(s): A.A. Davis, Sarita Agte, A. Pan, N. Mohindra, V. Villaflor, F.J. Giles
- Abstract
Loading... -
+
OA 07.03a - Impact of Tumor Mutation Burden on the Efficacy of Nivolumab or Nivolumab + Ipilimumab in Small Cell Lung Cancer: An Exploratory Analysis of CheckMate 032
16:15 - 16:25 | Presenter: Naiyer Rizvi | Author(s): S. Antonia, M.K. Callahan, M.M. Awad, Emiliano Calvo, P.A. Ascierto, A. Atmaca, Fred R. Hirsch, G. Selvaggi, J.D. Szustakowski, H. Chang, W.J. Geese, M.D. Hellmann
- Abstract
Loading... -
+
OA 07.04 - Discussant - OA 07.01, OA 07.02, OA 07.03, OA 07.03a
16:25 - 16:40 | Presenter: Balazs Halmos
- Abstract
No abstract available for this presentation
-
+
OA 07.05 - Serial Biopsies in Patients with EGFR-Mutant NSCLC Highlight the Spatial and Temporal Heterogeneity of Resistance Mechanisms
16:40 - 16:50 | Presenter: Zofia Piotrowska | Author(s): K. Stirling, R. Heist, M.J. Mooradian, C. Rizzo, S.R. Digumarthy, M. Lanuti, F. Fintelmann, I.T. Lennes, A.F. Farago, Justin F Gainor, C.G. Azzoli, J. Temel, Mari Mino-Kenudson, D. Dias-Santagata, R. Corcoran, Alice Shaw, A.N. Hata, Lecia V Sequist
- Abstract
Loading... -
+
OA 07.06 - Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions
16:50 - 17:00 | Presenter: Kenichi Suda | Author(s): J. Kim, I. Murakami, L. Rozeboom, C.J. Rivard, Tetsuya Mitsudomi, A. Tan, Fred R. Hirsch
- Abstract
Loading... -
+
OA 07.07 - Inhibition of the Novel Oncogene ELF3 Abolishes Lung Adenocarcinoma Growth
17:00 - 17:10 | Presenter: Katey S.S. Enfield | Author(s): Erin Anne Marshall, K. Ng, C. Anderson, S. Rahmati, Stephen Lam, C.E. Macaulay, W.W. Lockwood, A. Karsan, I. Jurisica, W.L. Lam
- Abstract
Loading... -
+
OA 07.08 - Clinical Potential of Sputum in Detecting Driver Mutations in Patients with Non-Small Cell Lung Cancer: A Preliminary Study
17:10 - 17:20 | Presenter: Vanessa Karen De Sá | Author(s): Helano Carioca Freitas, G.T. Torrezan, E.H.R. Olivieri, C.A. De Paula, D.M. Carraro, V.K. De Sa
- Abstract
Loading... -
+
OA 07.09 - Discussant - OA 07.05, OA 07.06, OA 07.07, OA 07.08
17:20 - 17:35 | Presenter: Iver Petersen
- Abstract
No abstract available for this presentation
-
+
PC 01 - 1-1. Surgery vs Non-Surgical Local Treatment for Small-Sized NSCLC
- 15:45 - 16:45
- 10/16/2017
- Location: Room 502
- Type: Pros & Cons
- Track: Early Stage NSCLC
- Moderators:David L Ball, H. Date
-
+
PC 01.01 - SABR as First Line Treatment Option
15:45 - 16:05 | Presenter: Hak Choy
- Abstract
Loading... -
+
PC 01.02 - Surgery as First Line Treatment Option
16:05 - 16:25 | Presenter: Robert John Downey
- Abstract
Loading... -
+
PC 01.03 - Other First Line Treatment Options
16:25 - 16:45 | Presenter: Hiran Fernando
- Abstract
Loading...
-
+
PC 01 - 1-2. What is the Role of Local Therapy in Non-CNS Oligometastatic NSCLC?
- 16:45 - 17:30
- 10/16/2017
- Location: Room 502
- Type: Pros & Cons
- Track: Advanced NSCLC
- Moderators:David L Ball, H. Date
-
+
PC 01.04 - There is a Role of Surgery in Non-CNS Oligometastatic Disease
16:45 - 17:05 | Presenter: Young Tae Kim
- Abstract
Loading... -
+
PC 01.05 - There is No Role of Surgery in Non-CNS Oligometastatic Disease
17:05 - 17:25 | Presenter: Egbert F Smit
- Abstract
No abstract available for this presentation
-
+
PC 01.06 - Q&A
17:25 - 17:30
- Abstract
No abstract available for this presentation
-
+
WS 05 - superDimension™ Electromagnetic Navigation Bronchoscopy - Bridging the Diagnostic and Therapeutic Domains in Lung Cancer
- 19:15 - 20:30
- 10/16/2017
- Location: Room 315
- Type: Workshop
- Track: Pulmonology/Endoscopy
- > View Program / Invitation (PDF)
-
+
WS 05.01 - Update on Global NAVIGATE Trial (first 1000 patients)
19:15 - 19:30
- Abstract
No abstract available for this presentation
-
+
WS 05.02 - Optimizing the Diagnostic Procedure
19:30 - 19:50 | Presenter: Christopher W Towe
- Abstract
No abstract available for this presentation
-
+
WS 05.03 - superDimension™ Beyond the Diagnosis
19:50 - 20:10 | Presenter: Mark R Bowling
- Abstract
No abstract available for this presentation
-
+
WS 05.04 - Q&A
20:10 - 20:30
- Abstract
No abstract available for this presentation